BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 23919928)

  • 1. Adverse drug reactions and off-label and unlicensed medicines in children: a prospective cohort study of unplanned admissions to a paediatric hospital.
    Bellis JR; Kirkham JJ; Nunn AJ; Pirmohamed M
    Br J Clin Pharmacol; 2014 Mar; 77(3):545-53. PubMed ID: 23919928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospital.
    Bellis JR; Kirkham JJ; Thiesen S; Conroy EJ; Bracken LE; Mannix HL; Bird KA; Duncan JC; Peak M; Turner MA; Smyth RL; Nunn AJ; Pirmohamed M
    BMC Med; 2013 Nov; 11():238. PubMed ID: 24229060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
    Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
    Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.
    Turner S; Nunn AJ; Fielding K; Choonara I
    Acta Paediatr; 1999 Sep; 88(9):965-8. PubMed ID: 10519338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is off-label use a risk factor for adverse drug reactions in pediatric patients? A prospective study in an Indian tertiary care hospital.
    Saiyed MM; Lalwani T; Rana D
    Int J Risk Saf Med; 2015; 27(1):45-53. PubMed ID: 25766066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
    Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
    Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions.
    Aagaard L; Hansen EH
    Br J Clin Pharmacol; 2011 May; 71(5):751-7. PubMed ID: 21241353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials.
    Mukattash T; Hawwa AF; Trew K; McElnay JC
    Eur J Clin Pharmacol; 2011 May; 67(5):449-61. PubMed ID: 21243345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia.
    Lee JL; Redzuan AM; Shah NM
    Int J Clin Pharm; 2013 Dec; 35(6):1025-9. PubMed ID: 24022725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of off-label and unlicensed paediatric prescribing in a hospital in Indonesia during the period Aug.-Oct. 2014.
    Tukayo BLA; Sunderland B; Parsons R; Czarniak P
    PLoS One; 2020; 15(1):e0227687. PubMed ID: 31935254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine.
    Khdour MR; Hallak HO; Alayasa KS; AlShahed QN; Hawwa AF; McElnay JC
    Int J Clin Pharm; 2011 Aug; 33(4):650-5. PubMed ID: 21567279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions in paediatric surgery: prospective study on frequency and risk related factors.
    Pérez-Ingidua C; Rivas-Paterna AB; González-Perrino C; Aleo-Luján E; Ascaso-Del-Rio A; Laredo-Velasco L; Portolés-Pérez A; Vargas-Castrillón E
    BMC Pediatr; 2024 May; 24(1):344. PubMed ID: 38760745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol.
    Nguyen KA; Mimouni Y; Jaberi E; Paret N; Boussaha I; Vial T; Jacqz-Aigrain E; Alberti C; Guittard L; Remontet L; Roche L; Bossard N; Kassai B
    Therapie; 2021; 76(6):675-685. PubMed ID: 33593598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label and unlicensed utilization of drugs in a Brazilian pediatric hospital.
    Pereira Gomes V; Melo da Silva K; Oliveira Chagas S; dos Santos Magalhães IR
    Farm Hosp; 2015 May; 39(3):176-80. PubMed ID: 26005894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Off-label and Unlicensed Medicines in Children.
    Lee JH; Byon HJ; Choi S; Jang YE; Kim EH; Kim JT; Kim HS
    J Korean Med Sci; 2018 Sep; 33(37):e227. PubMed ID: 30190655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label prescribing in pediatric outpatients.
    Palmaro A; Bissuel R; Renaud N; Durrieu G; Escourrou B; Oustric S; Montastruc JL; Lapeyre-Mestre M
    Pediatrics; 2015 Jan; 135(1):49-58. PubMed ID: 25511119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.
    Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT
    Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlicensed and off-label use of medicines at a neonatology clinic in Italy.
    Dell'Aera M; Gasbarro AR; Padovano M; Laforgia N; Capodiferro D; Solarino B; Quaranta R; Dell'Erba AS
    Pharm World Sci; 2007 Aug; 29(4):361-7. PubMed ID: 17351821
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.